Cargando…
Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality
INTRODUCTION: Pulmonary capillary endothelium-bound (PCEB) angiotensin-converting enzyme (ACE) activity is a direct and quantifiable index of pulmonary endothelial function that decreases early in acute respiratory distress syndrome (ARDS) and correlates with its severity. Endothelial dysfunction is...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856732/ https://www.ncbi.nlm.nih.gov/pubmed/29549655 http://dx.doi.org/10.1007/s40121-018-0192-3 |
_version_ | 1783307326846926848 |
---|---|
author | Kaziani, Katerina Vassiliou, Alice G. Kotanidou, Anastasia Athanasiou, Chariclea Korovesi, Ioanna Glynos, Konstantinos Orfanos, Stylianos E. |
author_facet | Kaziani, Katerina Vassiliou, Alice G. Kotanidou, Anastasia Athanasiou, Chariclea Korovesi, Ioanna Glynos, Konstantinos Orfanos, Stylianos E. |
author_sort | Kaziani, Katerina |
collection | PubMed |
description | INTRODUCTION: Pulmonary capillary endothelium-bound (PCEB) angiotensin-converting enzyme (ACE) activity is a direct and quantifiable index of pulmonary endothelial function that decreases early in acute respiratory distress syndrome (ARDS) and correlates with its severity. Endothelial dysfunction is a major pathophysiology that underlies sepsis-related ARDS. Recombinant human activated protein C (rhAPC), now withdrawn from the market, has been used in the recent past as an endothelial-protective treatment in patients with septic organ dysfunction. METHODS: We investigated the effect of rhAPC on pulmonary endothelial function in 19 septic patients suffering from ARDS. Applying indicator-dilution type techniques, we measured single-pass transpulmonary percent metabolism (%M) and hydrolysis (v) of the synthetic, biologically inactive, and highly specific for ACE substrate, (3)H-benzoyl-Phe-Ala-Pro (BPAP), under first-order reaction conditions, and calculated lung functional capillary surface area before and after treatment with rhAPC. RESULTS: Pulmonary endothelium ACE activity was severely impaired in septic patients with ARDS, and was not affected by rhAPC treatment. Additionally, poor outcome was related to a more profound decrease in PCEB-ACE activity. Angiotensin-converting enzyme–substrate utilization was statistically significantly lower in non-survivors as compared to survivors, with no changes over time within each group: BPAP %M: 32.7 ± 3.4% at baseline to 25.6 ± 2.9% at day 7 in survivors versus 20.8 ± 2.8 to 15.5 ± 5%, respectively, in non-survivors (p = 0.044), while hydrolysis (v): 0.41 ± 0.06 at baseline to 0.30 ± 0.04 at day 7 in survivors compared to 0.24 ± 0.04 to 0.18 ± 0.06, respectively, in non-survivors (p = 0.049). CONCLUSION: rhAPC administration in septic patients with ARDS did not improve PCEB-ACE activity indices. However, these indices might be useful in the early recognition of septic patients with ARDS at high risk of mortality. |
format | Online Article Text |
id | pubmed-5856732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-58567322018-03-21 Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality Kaziani, Katerina Vassiliou, Alice G. Kotanidou, Anastasia Athanasiou, Chariclea Korovesi, Ioanna Glynos, Konstantinos Orfanos, Stylianos E. Infect Dis Ther Original Research INTRODUCTION: Pulmonary capillary endothelium-bound (PCEB) angiotensin-converting enzyme (ACE) activity is a direct and quantifiable index of pulmonary endothelial function that decreases early in acute respiratory distress syndrome (ARDS) and correlates with its severity. Endothelial dysfunction is a major pathophysiology that underlies sepsis-related ARDS. Recombinant human activated protein C (rhAPC), now withdrawn from the market, has been used in the recent past as an endothelial-protective treatment in patients with septic organ dysfunction. METHODS: We investigated the effect of rhAPC on pulmonary endothelial function in 19 septic patients suffering from ARDS. Applying indicator-dilution type techniques, we measured single-pass transpulmonary percent metabolism (%M) and hydrolysis (v) of the synthetic, biologically inactive, and highly specific for ACE substrate, (3)H-benzoyl-Phe-Ala-Pro (BPAP), under first-order reaction conditions, and calculated lung functional capillary surface area before and after treatment with rhAPC. RESULTS: Pulmonary endothelium ACE activity was severely impaired in septic patients with ARDS, and was not affected by rhAPC treatment. Additionally, poor outcome was related to a more profound decrease in PCEB-ACE activity. Angiotensin-converting enzyme–substrate utilization was statistically significantly lower in non-survivors as compared to survivors, with no changes over time within each group: BPAP %M: 32.7 ± 3.4% at baseline to 25.6 ± 2.9% at day 7 in survivors versus 20.8 ± 2.8 to 15.5 ± 5%, respectively, in non-survivors (p = 0.044), while hydrolysis (v): 0.41 ± 0.06 at baseline to 0.30 ± 0.04 at day 7 in survivors compared to 0.24 ± 0.04 to 0.18 ± 0.06, respectively, in non-survivors (p = 0.049). CONCLUSION: rhAPC administration in septic patients with ARDS did not improve PCEB-ACE activity indices. However, these indices might be useful in the early recognition of septic patients with ARDS at high risk of mortality. Springer Healthcare 2018-03-16 2018-03 /pmc/articles/PMC5856732/ /pubmed/29549655 http://dx.doi.org/10.1007/s40121-018-0192-3 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Kaziani, Katerina Vassiliou, Alice G. Kotanidou, Anastasia Athanasiou, Chariclea Korovesi, Ioanna Glynos, Konstantinos Orfanos, Stylianos E. Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
title | Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
title_full | Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
title_fullStr | Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
title_full_unstemmed | Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
title_short | Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
title_sort | activated protein c has no effect on pulmonary capillary endothelial function in septic patients with acute respiratory distress syndrome: association of endothelial dysfunction with mortality |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856732/ https://www.ncbi.nlm.nih.gov/pubmed/29549655 http://dx.doi.org/10.1007/s40121-018-0192-3 |
work_keys_str_mv | AT kazianikaterina activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality AT vassilioualiceg activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality AT kotanidouanastasia activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality AT athanasiouchariclea activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality AT korovesiioanna activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality AT glynoskonstantinos activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality AT orfanosstylianose activatedproteinchasnoeffectonpulmonarycapillaryendothelialfunctioninsepticpatientswithacuterespiratorydistresssyndromeassociationofendothelialdysfunctionwithmortality |